BDBM50244718 CHEMBL460273::JNJ-1661010::N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide::cid_2809273

SMILES O=C(Nc1ccccc1)N1CCN(CC1)c1nc(ns1)-c1ccccc1

InChI Key InChIKey=BHBOSTKQCZEAJM-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 50244718   

TargetUbiquitin-conjugating enzyme E2 N(Homo sapiens (Human))
Burnham Center For Chemical Genomics

Curated by PubChem BioAssay
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50: >2.00E+4nMAssay Description:Data Source: Sanford-Burnham Center for Chemical Genomics (SBCCG) Source Affiliation: Sanford-Burnham Medical Research Institute (SBMRI, San Diego CA...More data for this Ligand-Target Pair
In DepthDetails PCBioAssay
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  15nMAssay Description:Inhibition of human FAAH preincubated for 40 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  70nMAssay Description:Inhibition of human FAAH preincubated for 10 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  34nMAssay Description:Inhibition of rat FAAH preincubated for 20 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  33nMAssay Description:Inhibition of human FAAH preincubated for 20 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  11nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  33nMAssay Description:Inhibition of FAAHMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  10nMAssay Description:Inhibition of rat FAAH assessed as hydrolysis of anandamidoaminomethylcumarinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  33nMAssay Description:Inhibition of FAAHMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  34nMAssay Description:Inhibition of rat FAAHMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50244718(CHEMBL460273 | JNJ-1661010 | N-phenyl-4-(3-phenyl-...)
Affinity DataIC50:  12nMAssay Description:Inhibition of human FAAH after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed